Cardiovascular Assessment of Pediatric Cancer Survivors: Understanding Long-Term Effects and Risks
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Left Ventricular Dysfunction
- Sponsor
- Istanbul University
- Enrollment
- 54
- Locations
- 1
- Primary Endpoint
- Rate of LV Dysfunction
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The goal of this observational study is to evaluate cardiac and vascular health status of pediatric cancer survivors.
Detailed Description
All pediatric cancer survivors were evaluated with cardiological examination, ECG, transthoracic echocardiography (transesophageal echocardiography when required), NT-proBNP, cTnI, kidney function tests, liver function tests, fasting blood glucose, cholesterol panel, iron, iron binding capacity, ferritin, transferrin saturation, B12, vitamin D, folic acid, urinanalysis, hemogram and a questionnaire about living with heart failure.
Investigators
Cafer Zorkun
Head, Division of CardioOncology
Istanbul University
Eligibility Criteria
Inclusion Criteria
- •Diagnosed cancer at pediatric age
Exclusion Criteria
- •Having cancer after 18 years of age
Outcomes
Primary Outcomes
Rate of LV Dysfunction
Time Frame: From the first visit at cardio-oncology division through study completion, an average of 2 years
Echocardiographic evaluation of left ventricular functions